Smartleaf Asset Management’s Pacira BioSciences PCRX Stock Holding History

Smartleaf Asset Management’s Portfolio PCRX Stock Details PCRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.83K	Hold	352	–	–	﹤0.01%	2417
2026 Q1	$8.19K	Sell	352 -410	-54%	-$9.11K	﹤0.01%	2422
2025 Q4	$19.9K	Buy	762 +183	+32%	+$4.35K	﹤0.01%	2038
2025 Q3	$14.7K	Buy	579 +410	+243%	+$10.1K	﹤0.01%	1948
2025 Q2	$3.97K	Sell	169 -249	-60%	-$6.28K	﹤0.01%	2122
2025 Q1	$10.4K	Sell	418 -7	-2%	-$168	﹤0.01%	1914
2024 Q4	$8.05K	Buy	425 +394	+1,271%	+$6.92K	﹤0.01%	2077
2024 Q3	$450	Sell	31 -236	-88%	-$4.04K	﹤0.01%	2791
2024 Q2	$7.45K	Buy	+267	New	+$7.6K	﹤0.01%	1577

Other funds holding PCRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

DPCM

Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Smartleaf Asset Management's PCRX Position: Q2 2026 in Review

Smartleaf Asset Management held its Pacira BioSciences (PCRX) position steady in Q2 2026 at 352 shares worth $8.83K. The position accounts for ﹤0.01% of the portfolio, ranked #2417.

Smartleaf Asset Management first reported a position in PCRX in Q2 2024 and has held it in 9 quarters since. The position peaked at $19.9K in Q4 2025. 254 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

Smartleaf Asset Management held 352 shares of Pacira BioSciences worth $8.83K as of Q2 2026.
Smartleaf Asset Management left its Pacira BioSciences share count unchanged in Q2 2026.
Pacira BioSciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #2417 holding.
Smartleaf Asset Management first reported a position in Pacira BioSciences in Q2 2024 and has held it in 9 quarters since.
Smartleaf Asset Management's Pacira BioSciences position peaked at $19.9K in Q4 2025.
254 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.